Home Beijing Tiantan Biological Products Co., Ltd.
B

Beijing Tiantan Biological Products Co., Ltd.

Profile managed by Bizz Id
China 1998

Description

Beijing Tiantan Biological Products is one of China's largest plasma-derived medicine manufacturers and part of China National Biotec Group (CNBG), within Sinopharm. The company is listed on the Shanghai Stock Exchange under code 600161 and reports a network of 107 plasmapheresis stations across 16 Chinese provinces. Its portfolio covers the classic fractionation families: human albumin, intravenous immunoglobulin, specific hyperimmune immunoglobulins, coagulation factors and antithrombin. Production is spread across eight fractionation and finishing plants in Chengdu, Lanzhou, Shanghai, Wuhan, Kaili, Xi'an and Kunming, together with the Wuhan Zhongyuan Ruide subsidiary.

Products

16 products
Freeze-dried Human Hepatitis B Immunoglobulin for Intravenous Injection

Freeze-dried intravenous hepatitis B immunoglobulin; Rongsheng brand.

Tech pack available

Finished product (FDF)

Chengdu Rongsheng
NMPA (China)

Verified on 2026-10-17

Hepatitis B Immunoglobulin: see suppliers →

Human Albumin

Plasma-derived human albumin; Rongsheng and Shangsheng brands; 10 g presentation published. Made at Chengdu Rongsheng, Tiantan Lanzhou, Tiantan Shanghai, Tiantan Wuhan, Tiantan Guizhou, Tiantan Xi'an and Wuhan Zhongyuan Ruide.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Albumin: see suppliers →

Human Antithrombin III

R&D project stated to be under way at Tiantan Lanzhou.

Under development

Finished product (FDF)

Verified on 2026-10-17

Antithrombin III: see suppliers →

Human Coagulation Factor IX

Project in the company's R&D pipeline.

Under development

Finished product (FDF)

Verified on 2026-10-17

Factor IX: see suppliers →

Human Coagulation Factor VIII

Plasma-derived factor VIII for haemophilia A.

Tech pack available

Finished product (FDF)

Chengdu Rongsheng
NMPA (China)

Verified on 2026-10-17

Factor VIII: see suppliers →

Human Fibrinogen

Plasma-derived fibrinogen for haemostasis.

Tech pack available

Finished product (FDF)

Chengdu Rongsheng
NMPA (China)

Verified on 2026-10-17

Fibrinogen: see suppliers →

Human Hepatitis B Immunoglobulin

Hepatitis B specific immunoglobulin. Made at Tiantan Xi'an and Tiantan Guizhou; Tiantan Lanzhou states it is qualified to produce it.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Hepatitis B Immunoglobulin: see suppliers →

Human Immunoglobulin (pH4) for Intravenous Injection

Intravenous immunoglobulin; Rongsheng Jingbing brand, including the fourth-generation 10% chromatography product; 2.5 g presentation published. Made at Chengdu Rongsheng, Tiantan Lanzhou, Tiantan Shanghai, Tiantan Wuhan, Tiantan Guizhou, Tiantan Xi'an and Wuhan Zhongyuan Ruide.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Immunoglobulin: see suppliers →

Human Immunoglobulin for Intramuscular Injection

Normal human immunoglobulin. Made at Tiantan Xi'an, Tiantan Guizhou and Tiantan Shanghai; Tiantan Lanzhou states it is qualified to produce it.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Immunoglobulin: see suppliers →

Human Immunoglobulin for Subcutaneous Injection

Project in the company's R&D pipeline.

Under development

Finished product (FDF)

Verified on 2026-10-17

Immunoglobulin: see suppliers →

Human Prothrombin Complex

Prothrombin complex concentrate; 300 IU presentation published for the new Lanzhou base. Made at Chengdu Rongsheng and Tiantan Lanzhou.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Prothrombin Complex: see suppliers →

Human Rabies Immunoglobulin

Rabies specific immunoglobulin. Made at Chengdu Rongsheng and Tiantan Wuhan.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Rabies Immunoglobulin: see suppliers →

Human Tetanus Immunoglobulin

Tetanus specific immunoglobulin; Chengdu Rongsheng states it was the first in China to launch it. Also made at Tiantan Guizhou.

Tech pack available

Finished product (FDF)

Verified on 2026-10-17

Tetanus Immunoglobulin: see suppliers →

Recombinant Human Coagulation Factor VIIa for Injection

Project in the company's R&D pipeline.

Under development

Finished product (FDF)

Verified on 2026-10-17

Factor VIIa: see suppliers →

Recombinant Human Coagulation Factor VIII for Injection

Recombinant factor VIII for haemophilia A; the company states it is the first such product developed in China's plasma-products sector.

Tech pack available

Finished product (FDF)

Chengdu Rongsheng
NMPA (China)

Verified on 2026-10-17

Factor VIII: see suppliers →

Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

Project in the company's R&D pipeline.

Under development

Finished product (FDF)

Verified on 2026-10-17

Factor VIII: see suppliers →

Certifications

NMPA

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free

Other locations

Chengdu Rongsheng
Chengdu Rongsheng (China)
Tiantan Lanzhou
Lanzhou High-tech Zone (new production base) (China)
Tiantan Shanghai
Building 54, No. 350 Anshun Road, Changning District, Shanghai (China)
Tiantan Wuhan
Tiantan Wuhan (China)
Tiantan Guizhou
Tiantan Guizhou, Kaili (China)
Tiantan Xi'an
Baliu Second Road, Xi'an Modern Textile Industrial Park (China)
Wuhan Zhongyuan Ruide
Wuhan Optics Valley Biopark (China)
Tiantan Kunming
Dianzhong New Area, Kunming (China)